Clinical Trial Update: Saffron Supplementation in Stargardt's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating saffron supplementation for Stargardt disease is noted, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• Saffron (saffron extract)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Retinal Degeneration, Genetic Disease | Phase 1, Phase 2 | Status: UNKNOWN